Cargando…

Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery

Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a long time, but still, the knowledge about this concatenation is incomplete. Sarcoidosis-associated PH (SAPH) is an uncommon but serious complication associated with increased morbidity and mortality among sarcoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kacprzak, Aneta, Tomkowski, Witold, Szturmowicz, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572558/ https://www.ncbi.nlm.nih.gov/pubmed/37835874 http://dx.doi.org/10.3390/diagnostics13193132

Ejemplares similares

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy
por: Kacprzak, Aneta, et al.
Publicado: (2023)

Imaging Plays a Key Role in the Diagnosis and Control of the Treatment of Bone Sarcoidosis
por: Błasińska, Katarzyna, et al.
Publicado: (2023)

Atypical Pulmonary Tuberculosis as the First Manifestation of Advanced HIV Disease—Diagnostic Difficulties
por: Kacprzak, Aneta, et al.
Publicado: (2022)

Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
por: Sobiecka, Małgorzata, et al.
Publicado: (2020)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

Pulmonary hypertension associated with sarcoidosis
por: Baughman, Robert P
Publicado: (2007)

Severe Respiratory Failure Due to Pulmonary BCGosis in a Patient Treated for Superficial Bladder Cancer
por: Lewandowska, Katarzyna, et al.
Publicado: (2022)

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series
por: Dybowska, Małgorzata, et al.
Publicado: (2020)

Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis
por: Dybowska, Małgorzata, et al.
Publicado: (2022)

Tuberculous Pericarditis—Own Experiences and Recent Recommendations
por: Dybowska, Małgorzata, et al.
Publicado: (2022)

Combined Emphysema and Interstitial Lung Disease as a Rare Presentation of Pulmonary Involvement in a Patient with Chronic Visceral Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B)
por: Opoka, Lucyna, et al.
Publicado: (2020)

In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans
por: Szturmowicz, Monika, et al.
Publicado: (2010)

A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with Deep Vein Thrombosis and Pulmonary Thromboembolism
por: Goljan-Geremek, Anna, et al.
Publicado: (2021)

Pulmonary hypertension complicating pulmonary sarcoidosis
por: Huitema, M. P., et al.
Publicado: (2016)

Sudden Vision Loss Due to Optic Neuritis—An Uncommon Presentation of Neurosarcoidosis
por: Zimna, Katarzyna, et al.
Publicado: (2023)

D-Dimers Variability in the Perioperative Period of Breast Cancer Surgery Helps to Predict Cancer Relapse: A Single-Centre Prospective Study
por: Dybowska, Małgorzata, et al.
Publicado: (2023)

Acute Eosinophilic Pneumonia Complicated with Venous Thromboembolic Disease—Diagnostic and Therapeutic Considerations
por: Jankowska, Ewa, et al.
Publicado: (2022)

Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension
por: Groen, Karlijn, et al.
Publicado: (2022)

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

The value of serum precipitins against specific antigens in patients diagnosed with hypersensitivity pneumonitis – retrospective study
por: SZTURMOWICZ, MONIKA, et al.
Publicado: (2020)

Large Pericardial Effusion—Diagnostic and Therapeutic Options, with a Special Attention to the Role of Prolonged Pericardial Fluid Drainage
por: Dybowska, Małgorzata, et al.
Publicado: (2022)

Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Sobiecka, Małgorzata, et al.
Publicado: (2023)

A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension
por: Bazmpani, Maria Anna, et al.
Publicado: (2018)

Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study
por: Sobiecka, Małgorzata, et al.
Publicado: (2021)

Echocardiographic signs of pulmonary hypertension in patients with newly recognized hypersensitivity pneumonitis, prevalence and clinical predictors
por: Dybowska, Małgorzata, et al.
Publicado: (2021)

Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients
por: Mirsaeidi, Mehdi, et al.
Publicado: (2016)

Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension
por: Parikh, Kishan S., et al.
Publicado: (2019)

Pulmonary Function in Pulmonary Sarcoidosis
por: Yao, Qian, et al.
Publicado: (2023)

The mystery of persistent pulmonary hypertension: an idiopathic infantile arterial calcification
por: Shaireen, Huma, et al.
Publicado: (2013)

Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement
por: Szturmowicz, Monika, et al.
Publicado: (2021)

Pulmonary fibrosis in sarcoidosis
por: Asif, Huda, et al.
Publicado: (2023)

The Symptoms of Pulmonary Sarcoidosis
por: Judson, Marc A.
Publicado: (2023)

Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series
por: Mathijssen, H., et al.
Publicado: (2020)

Multifactorial Etiology Pulmonary Hypertension in a Patient with Sarcoidosis
por: Ana Terra Fonseca, Barreto, et al.
Publicado: (2016)

Sarcoidosis-associated pulmonary fibrosis: joining the dots
por: Bandyopadhyay, Debabrata, et al.
Publicado: (2023)

Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
por: Alhamad, Esam H., et al.
Publicado: (2010)

New 6-Minute-Walking Test Parameter—Distance/Desaturation Index (DDI) Correctly Diagnoses Short-Term Response to Immunomodulatory Therapy in Hypersensitivity Pneumonitis
por: Lewandowska, Katarzyna B., et al.
Publicado: (2023)

Altered miRNA expression in pulmonary sarcoidosis
por: Kiszałkiewicz, Justyna, et al.
Publicado: (2016)

Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis
por: Jose, Arun, et al.
Publicado: (2018)

Prevalence of Sarcoidosis-Associated Pulmonary Hypertension: A Systematic Review and Meta-Analysis
por: Zhang, Shijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6v4p88h65891t1v6tmpmq77p1r